| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/26/2003 | EP1363908A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM |
| 11/26/2003 | EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 11/26/2003 | EP1363904A1 Pyrazoles as tgf inhibitors |
| 11/26/2003 | EP1363903A1 Indole derivatives and their use as gnrh antagonists |
| 11/26/2003 | EP1363900A1 Isoindole-imide compounds as tnf-inhibitors |
| 11/26/2003 | EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 11/26/2003 | EP1363892A1 Stable pharmaceutical form of an anticancer drug |
| 11/26/2003 | EP1363891A2 Anthrone derivatives and their use as jnk inhibitors |
| 11/26/2003 | EP1363888A2 Therapeutic acridone and acridine compounds |
| 11/26/2003 | EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 11/26/2003 | EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 11/26/2003 | EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 11/26/2003 | EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 11/26/2003 | EP1363874A2 Tryptase inhibitors |
| 11/26/2003 | EP1363702A1 Methods of inhibiting kinases |
| 11/26/2003 | EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 11/26/2003 | EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer |
| 11/26/2003 | EP1363667A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 11/26/2003 | EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies |
| 11/26/2003 | EP1363651A1 Herbal compositions useful as chemopreventive and therapeutic agents |
| 11/26/2003 | EP1363646A1 Preparation of cartilage extracts using organic solvents |
| 11/26/2003 | EP1363640A2 Nucleic acid derivatives |
| 11/26/2003 | EP1363637A1 Pyrimidine compounds and methods for making and using the same |
| 11/26/2003 | EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 11/26/2003 | EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles |
| 11/26/2003 | EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 11/26/2003 | EP1363627A2 Treatment of solid tumours with rapamycin derivatives |
| 11/26/2003 | EP1363625A1 Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
| 11/26/2003 | EP1363620A2 Use of fredericamycin and its derivatives in the treatment of pin1-associated states |
| 11/26/2003 | EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 11/26/2003 | EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 11/26/2003 | EP1363601A2 Amphoteric liposomes and the use thereof |
| 11/26/2003 | EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs |
| 11/26/2003 | EP1363508A1 Emulsions and aqueous dispersions of phytosterols |
| 11/26/2003 | EP1363504A1 Process for the fractionation of cereal brans |
| 11/26/2003 | EP1268487B1 Tricyclic protein kinase inhibitors |
| 11/26/2003 | EP1259523B1 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 11/26/2003 | EP1258490B1 Process for preparing indolopyrrolocarbazole derivatives, intermediates thereof, and preparation process of the intermediates |
| 11/26/2003 | EP1186610B1 Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents |
| 11/26/2003 | EP1028977B1 Bifidus stimulating peptides and their uses |
| 11/26/2003 | EP1025096B1 Substituted chroman derivatives |
| 11/26/2003 | EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 11/26/2003 | EP0871492B1 Mesothelium antigen and methods and kits for targeting it |
| 11/26/2003 | EP0859627B1 Mimicking peptides in cancer therapy |
| 11/26/2003 | EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8 |
| 11/26/2003 | EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same |
| 11/26/2003 | EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 11/26/2003 | EP0590058B1 HUMANIZED Heregulin ANTIBODy |
| 11/26/2003 | CN1458979A Modulating multiple lineage kinase proteins |
| 11/26/2003 | CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 11/26/2003 | CN1458929A Chemokine receptor binding heterocyclic compounds |
| 11/26/2003 | CN1458926A Nitric oxide donors based on metallic centres |
| 11/26/2003 | CN1458841A Use of matrix metalloprotease ihibitors for treatment of cancer |
| 11/26/2003 | CN1458170A New human protein with cancer inhibiting function and its encoding sequence |
| 11/26/2003 | CN1458156A Rare-earth compounds and their preparing method and use in preparing tumour treating medicine |
| 11/26/2003 | CN1458155A New anti-cancer active compound-Bulbophyllum phenol B |
| 11/26/2003 | CN1458154A New anti-cancer active compound-Bulbophyllum phenol A |
| 11/26/2003 | CN1458146A Casodex synthesizing process for anti-tumour medicine |
| 11/26/2003 | CN1457882A Recombined human interleukin-2 and its derivative injection and preparing method |
| 11/26/2003 | CN1457880A Polyresistin dripping pill and its preparing method for immunodeficiency |
| 11/26/2003 | CN1457849A Specific medicine for curing carcinoma of stomach |
| 11/26/2003 | CN1457842A Cancer preventing and curing Chinese medicine of two snakes and Ganoderma Lucidum seu Japonicum |
| 11/26/2003 | CN1457837A Chinese medicine for curing carcinoma of stomach |
| 11/26/2003 | CN1457830A Compound Chinese medicine preparation for curing asthma and assisted curing tumor and AIDS and its preparing method |
| 11/26/2003 | CN1457809A Dandelion preparation and preparing method |
| 11/26/2003 | CN1457806A Medicine for curing primary carcinoma of liver and its preparing method |
| 11/26/2003 | CN1457805A Chinese medicine preparation for curing eophagus cancer |
| 11/26/2003 | CN1457798A Hydroypropyl-beta-cyclodextrin inclusion of Rhizoma Zedoariae oil and preparation and preparing method |
| 11/26/2003 | CN1457789A Medicinal composition containing triphenyl-boroxin for boron neutron catching treatment |
| 11/26/2003 | CN1457788A Use of 2-methoxy estrodiol in making medicines |
| 11/26/2003 | CN1457780A Total alkaloid composition from plant and its pharmaceutical preparation |
| 11/26/2003 | CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method |
| 11/26/2003 | CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use |
| 11/26/2003 | CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles |
| 11/26/2003 | CN1128795C Semi-synthetic taxane having anti-tumor activity |
| 11/26/2003 | CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| 11/26/2003 | CN1128618C Use of histamine for elevating blood histamine |
| 11/26/2003 | CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 11/25/2003 | US6653493 Lipoxin compounds and their use in treating cell proliferative disorders |
| 11/25/2003 | US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same |
| 11/25/2003 | US6653445 Chemotactic cytokine V (CCV); isolated protein of given sequence; use in diagnostics and as anti-viral or anti-tumor agent |
| 11/25/2003 | US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability |
| 11/25/2003 | US6653347 For therapy |
| 11/25/2003 | US6653327 Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
| 11/25/2003 | US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 11/25/2003 | US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof |
| 11/25/2003 | US6653320 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents |
| 11/25/2003 | US6653313 1,4-dihydropyridine compounds as bradykinin antagonists |
| 11/25/2003 | US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 11/25/2003 | US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8) |
| 11/25/2003 | US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents |
| 11/25/2003 | US6653301 For therapy of cancer, diabetes and Alzheimer's disease |
| 11/25/2003 | US6653300 Pyrazole compounds useful as protein kinase inhibitors |
| 11/25/2003 | US6653299 Labelled factor XIIIa substrates |
| 11/25/2003 | US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides |
| 11/25/2003 | US6653290 Tumor proliferation inhibitors |
| 11/25/2003 | US6653289 Anticancer drugs; reduced side effects |
| 11/25/2003 | US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 11/25/2003 | US6653278 Selenium-containing pro-drugs for cancer therapy |
| 11/25/2003 | US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke |